ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rabies Immune Globulin (Equine) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-14H14925
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Rabies Immune Globulin Equine Market Research Report 2023
BUY CHAPTERS

Global Rabies Immune Globulin (Equine) Market Research Report 2025

Code: QYRE-Auto-14H14925
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
Serum China
Premium Serums
Intas
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums and Vaccines
GlaxoSmithKline PLC
Vins Bioproducts
CSL Behring
Aventis Pasteur India

Rabies Immune Globulin (Equine) Market Size

The global market for Rabies Immune Globulin (Equine) was valued at US$ 1281 million in the year 2024 and is projected to reach a revised size of US$ 1624 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Rabies Immune Globulin (Equine) Market

Rabies Immune Globulin (Equine) Market

Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Immune Globulin (Equine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Immune Globulin (Equine).
The Rabies Immune Globulin (Equine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rabies Immune Globulin (Equine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Immune Globulin (Equine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rabies Immune Globulin (Equine) Market Report

Report Metric Details
Report Name Rabies Immune Globulin (Equine) Market
Accounted market size in year US$ 1281 million
Forecasted market size in 2031 US$ 1624 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 1500IU
  • 1000IU
  • 400IU
  • Others
Segment by Application
  • Clinic
  • Hospital
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Grifols, Serum China, Premium Serums, Intas, Aventis Pasteur India, Cadila Pharmaceuticals, Zydus Takeda Healthcare, Bharat Serums And Vaccines, GlaxoSmithKline GmbH, VINS Bioproducts, CSL Behring
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rabies Immune Globulin (Equine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rabies Immune Globulin (Equine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Rabies Immune Globulin (Equine) Market growing?

Ans: The Rabies Immune Globulin (Equine) Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Rabies Immune Globulin (Equine) Market size in 2031?

Ans: The Rabies Immune Globulin (Equine) Market size in 2031 will be US$ 1624 million.

Who are the main players in the Rabies Immune Globulin (Equine) Market report?

Ans: The main players in the Rabies Immune Globulin (Equine) Market are Grifols, Serum China, Premium Serums, Intas, Aventis Pasteur India, Cadila Pharmaceuticals, Zydus Takeda Healthcare, Bharat Serums And Vaccines, GlaxoSmithKline GmbH, VINS Bioproducts, CSL Behring

What are the Application segmentation covered in the Rabies Immune Globulin (Equine) Market report?

Ans: The Applications covered in the Rabies Immune Globulin (Equine) Market report are Clinic, Hospital

What are the Type segmentation covered in the Rabies Immune Globulin (Equine) Market report?

Ans: The Types covered in the Rabies Immune Globulin (Equine) Market report are 1500IU, 1000IU, 400IU, Others

Recommended Reports

Rabies & Immunoglobulins

Animal Vaccines & Sera

Immunoglobulins & Antibodies

1 Rabies Immune Globulin (Equine) Market Overview
1.1 Product Definition
1.2 Rabies Immune Globulin (Equine) by Type
1.2.1 Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2024 VS 2031)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Others
1.3 Rabies Immune Globulin (Equine) by Application
1.3.1 Global Rabies Immune Globulin (Equine) Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Rabies Immune Globulin (Equine) Market Size Estimates and Forecasts
1.4.1 Global Rabies Immune Globulin (Equine) Revenue 2020-2031
1.4.2 Global Rabies Immune Globulin (Equine) Sales 2020-2031
1.4.3 Global Rabies Immune Globulin (Equine) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rabies Immune Globulin (Equine) Market Competition by Manufacturers
2.1 Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rabies Immune Globulin (Equine) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rabies Immune Globulin (Equine), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Type & Application
2.7 Global Key Manufacturers of Rabies Immune Globulin (Equine), Date of Enter into This Industry
2.8 Global Rabies Immune Globulin (Equine) Market Competitive Situation and Trends
2.8.1 Global Rabies Immune Globulin (Equine) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rabies Immune Globulin (Equine) Players Market Share by Revenue
2.8.3 Global Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rabies Immune Globulin (Equine) Market Scenario by Region
3.1 Global Rabies Immune Globulin (Equine) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rabies Immune Globulin (Equine) Sales by Region: 2020-2031
3.2.1 Global Rabies Immune Globulin (Equine) Sales by Region: 2020-2025
3.2.2 Global Rabies Immune Globulin (Equine) Sales by Region: 2026-2031
3.3 Global Rabies Immune Globulin (Equine) Revenue by Region: 2020-2031
3.3.1 Global Rabies Immune Globulin (Equine) Revenue by Region: 2020-2025
3.3.2 Global Rabies Immune Globulin (Equine) Revenue by Region: 2026-2031
3.4 North America Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.4.1 North America Rabies Immune Globulin (Equine) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rabies Immune Globulin (Equine) Sales by Country (2020-2031)
3.4.3 North America Rabies Immune Globulin (Equine) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.5.1 Europe Rabies Immune Globulin (Equine) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rabies Immune Globulin (Equine) Sales by Country (2020-2031)
3.5.3 Europe Rabies Immune Globulin (Equine) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Immune Globulin (Equine) Market Facts & Figures by Region
3.6.1 Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2020-2031)
3.6.3 Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.7.1 Latin America Rabies Immune Globulin (Equine) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rabies Immune Globulin (Equine) Sales by Country (2020-2031)
3.7.3 Latin America Rabies Immune Globulin (Equine) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rabies Immune Globulin (Equine) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rabies Immune Globulin (Equine) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Immune Globulin (Equine) Sales by Type (2020-2031)
4.1.1 Global Rabies Immune Globulin (Equine) Sales by Type (2020-2025)
4.1.2 Global Rabies Immune Globulin (Equine) Sales by Type (2026-2031)
4.1.3 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2020-2031)
4.2 Global Rabies Immune Globulin (Equine) Revenue by Type (2020-2031)
4.2.1 Global Rabies Immune Globulin (Equine) Revenue by Type (2020-2025)
4.2.2 Global Rabies Immune Globulin (Equine) Revenue by Type (2026-2031)
4.2.3 Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2020-2031)
4.3 Global Rabies Immune Globulin (Equine) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rabies Immune Globulin (Equine) Sales by Application (2020-2031)
5.1.1 Global Rabies Immune Globulin (Equine) Sales by Application (2020-2025)
5.1.2 Global Rabies Immune Globulin (Equine) Sales by Application (2026-2031)
5.1.3 Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2020-2031)
5.2 Global Rabies Immune Globulin (Equine) Revenue by Application (2020-2031)
5.2.1 Global Rabies Immune Globulin (Equine) Revenue by Application (2020-2025)
5.2.2 Global Rabies Immune Globulin (Equine) Revenue by Application (2026-2031)
5.2.3 Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2020-2031)
5.3 Global Rabies Immune Globulin (Equine) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Company Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Grifols Rabies Immune Globulin (Equine) Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 Serum China
6.2.1 Serum China Company Information
6.2.2 Serum China Description and Business Overview
6.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Serum China Rabies Immune Globulin (Equine) Product Portfolio
6.2.5 Serum China Recent Developments/Updates
6.3 Premium Serums
6.3.1 Premium Serums Company Information
6.3.2 Premium Serums Description and Business Overview
6.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Premium Serums Rabies Immune Globulin (Equine) Product Portfolio
6.3.5 Premium Serums Recent Developments/Updates
6.4 Intas
6.4.1 Intas Company Information
6.4.2 Intas Description and Business Overview
6.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Intas Rabies Immune Globulin (Equine) Product Portfolio
6.4.5 Intas Recent Developments/Updates
6.5 Aventis Pasteur India
6.5.1 Aventis Pasteur India Company Information
6.5.2 Aventis Pasteur India Description and Business Overview
6.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolio
6.5.5 Aventis Pasteur India Recent Developments/Updates
6.6 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Company Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolio
6.6.5 Cadila Pharmaceuticals Recent Developments/Updates
6.7 Zydus Takeda Healthcare
6.7.1 Zydus Takeda Healthcare Company Information
6.7.2 Zydus Takeda Healthcare Description and Business Overview
6.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolio
6.7.5 Zydus Takeda Healthcare Recent Developments/Updates
6.8 Bharat Serums And Vaccines
6.8.1 Bharat Serums And Vaccines Company Information
6.8.2 Bharat Serums And Vaccines Description and Business Overview
6.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolio
6.8.5 Bharat Serums And Vaccines Recent Developments/Updates
6.9 GlaxoSmithKline GmbH
6.9.1 GlaxoSmithKline GmbH Company Information
6.9.2 GlaxoSmithKline GmbH Description and Business Overview
6.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolio
6.9.5 GlaxoSmithKline GmbH Recent Developments/Updates
6.10 VINS Bioproducts
6.10.1 VINS Bioproducts Company Information
6.10.2 VINS Bioproducts Description and Business Overview
6.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolio
6.10.5 VINS Bioproducts Recent Developments/Updates
6.11 CSL Behring
6.11.1 CSL Behring Company Information
6.11.2 CSL Behring Description and Business Overview
6.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CSL Behring Rabies Immune Globulin (Equine) Product Portfolio
6.11.5 CSL Behring Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Immune Globulin (Equine) Industry Chain Analysis
7.2 Rabies Immune Globulin (Equine) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Immune Globulin (Equine) Production Mode & Process Analysis
7.4 Rabies Immune Globulin (Equine) Sales and Marketing
7.4.1 Rabies Immune Globulin (Equine) Sales Channels
7.4.2 Rabies Immune Globulin (Equine) Distributors
7.5 Rabies Immune Globulin (Equine) Customer Analysis
8 Rabies Immune Globulin (Equine) Market Dynamics
8.1 Rabies Immune Globulin (Equine) Industry Trends
8.2 Rabies Immune Globulin (Equine) Market Drivers
8.3 Rabies Immune Globulin (Equine) Market Challenges
8.4 Rabies Immune Globulin (Equine) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Grifols S A
Serum China
Premium Serums
Intas
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums and Vaccines
GlaxoSmithKline PLC
Vins Bioproducts
CSL Behring
Aventis Pasteur India
List of Tables
 Table 1. Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rabies Immune Globulin (Equine) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rabies Immune Globulin (Equine) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rabies Immune Globulin (Equine) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rabies Immune Globulin (Equine) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rabies Immune Globulin (Equine), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Type & Application
 Table 12. Global Key Manufacturers of Rabies Immune Globulin (Equine), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rabies Immune Globulin (Equine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rabies Immune Globulin (Equine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2020-2025)
 Table 19. Global Rabies Immune Globulin (Equine) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2026-2031)
 Table 21. Global Rabies Immune Globulin (Equine) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2020-2025)
 Table 23. Global Rabies Immune Globulin (Equine) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2026-2031)
 Table 25. North America Rabies Immune Globulin (Equine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rabies Immune Globulin (Equine) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rabies Immune Globulin (Equine) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rabies Immune Globulin (Equine) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rabies Immune Globulin (Equine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rabies Immune Globulin (Equine) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rabies Immune Globulin (Equine) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rabies Immune Globulin (Equine) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rabies Immune Globulin (Equine) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rabies Immune Globulin (Equine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rabies Immune Globulin (Equine) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rabies Immune Globulin (Equine) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rabies Immune Globulin (Equine) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rabies Immune Globulin (Equine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rabies Immune Globulin (Equine) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rabies Immune Globulin (Equine) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rabies Immune Globulin (Equine) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rabies Immune Globulin (Equine) Sales (K Units) by Type (2020-2025)
 Table 51. Global Rabies Immune Globulin (Equine) Sales (K Units) by Type (2026-2031)
 Table 52. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2020-2025)
 Table 53. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2026-2031)
 Table 54. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2020-2025)
 Table 57. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2026-2031)
 Table 58. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Rabies Immune Globulin (Equine) Sales (K Units) by Application (2020-2025)
 Table 61. Global Rabies Immune Globulin (Equine) Sales (K Units) by Application (2026-2031)
 Table 62. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2020-2025)
 Table 63. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2026-2031)
 Table 64. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2020-2025)
 Table 67. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2026-2031)
 Table 68. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Application (2026-2031)
 Table 70. Grifols Company Information
 Table 71. Grifols Description and Business Overview
 Table 72. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Grifols Rabies Immune Globulin (Equine) Product
 Table 74. Grifols Recent Developments/Updates
 Table 75. Serum China Company Information
 Table 76. Serum China Description and Business Overview
 Table 77. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Serum China Rabies Immune Globulin (Equine) Product
 Table 79. Serum China Recent Developments/Updates
 Table 80. Premium Serums Company Information
 Table 81. Premium Serums Description and Business Overview
 Table 82. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Premium Serums Rabies Immune Globulin (Equine) Product
 Table 84. Premium Serums Recent Developments/Updates
 Table 85. Intas Company Information
 Table 86. Intas Description and Business Overview
 Table 87. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Intas Rabies Immune Globulin (Equine) Product
 Table 89. Intas Recent Developments/Updates
 Table 90. Aventis Pasteur India Company Information
 Table 91. Aventis Pasteur India Description and Business Overview
 Table 92. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aventis Pasteur India Rabies Immune Globulin (Equine) Product
 Table 94. Aventis Pasteur India Recent Developments/Updates
 Table 95. Cadila Pharmaceuticals Company Information
 Table 96. Cadila Pharmaceuticals Description and Business Overview
 Table 97. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product
 Table 99. Cadila Pharmaceuticals Recent Developments/Updates
 Table 100. Zydus Takeda Healthcare Company Information
 Table 101. Zydus Takeda Healthcare Description and Business Overview
 Table 102. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product
 Table 104. Zydus Takeda Healthcare Recent Developments/Updates
 Table 105. Bharat Serums And Vaccines Company Information
 Table 106. Bharat Serums And Vaccines Description and Business Overview
 Table 107. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product
 Table 109. Bharat Serums And Vaccines Recent Developments/Updates
 Table 110. GlaxoSmithKline GmbH Company Information
 Table 111. GlaxoSmithKline GmbH Description and Business Overview
 Table 112. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product
 Table 114. GlaxoSmithKline GmbH Recent Developments/Updates
 Table 115. VINS Bioproducts Company Information
 Table 116. VINS Bioproducts Description and Business Overview
 Table 117. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. VINS Bioproducts Rabies Immune Globulin (Equine) Product
 Table 119. VINS Bioproducts Recent Developments/Updates
 Table 120. CSL Behring Company Information
 Table 121. CSL Behring Description and Business Overview
 Table 122. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. CSL Behring Rabies Immune Globulin (Equine) Product
 Table 124. CSL Behring Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Rabies Immune Globulin (Equine) Distributors List
 Table 128. Rabies Immune Globulin (Equine) Customers List
 Table 129. Rabies Immune Globulin (Equine) Market Trends
 Table 130. Rabies Immune Globulin (Equine) Market Drivers
 Table 131. Rabies Immune Globulin (Equine) Market Challenges
 Table 132. Rabies Immune Globulin (Equine) Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rabies Immune Globulin (Equine)
 Figure 2. Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rabies Immune Globulin (Equine) Market Share by Type: 2024 & 2031
 Figure 4. 1500IU Product Picture
 Figure 5. 1000IU Product Picture
 Figure 6. 400IU Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Rabies Immune Globulin (Equine) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Rabies Immune Globulin (Equine) Market Share by Application: 2024 & 2031
 Figure 10. Clinic
 Figure 11. Hospital
 Figure 12. Global Rabies Immune Globulin (Equine) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Rabies Immune Globulin (Equine) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Rabies Immune Globulin (Equine) Sales (2020-2031) & (K Units)
 Figure 15. Global Rabies Immune Globulin (Equine) Average Price (US$/Unit) & (2020-2031)
 Figure 16. Rabies Immune Globulin (Equine) Report Years Considered
 Figure 17. Rabies Immune Globulin (Equine) Sales Share by Manufacturers in 2024
 Figure 18. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Rabies Immune Globulin (Equine) Players: Market Share by Revenue in Rabies Immune Globulin (Equine) in 2024
 Figure 20. Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Rabies Immune Globulin (Equine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Rabies Immune Globulin (Equine) Sales Market Share by Country (2020-2031)
 Figure 23. North America Rabies Immune Globulin (Equine) Revenue Market Share by Country (2020-2031)
 Figure 24. United States Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Rabies Immune Globulin (Equine) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Rabies Immune Globulin (Equine) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Rabies Immune Globulin (Equine) Revenue Market Share by Region (2020-2031)
 Figure 35. China Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Rabies Immune Globulin (Equine) Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Rabies Immune Globulin (Equine) Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Rabies Immune Globulin (Equine) Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Rabies Immune Globulin (Equine) Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Rabies Immune Globulin (Equine) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Rabies Immune Globulin (Equine) by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Rabies Immune Globulin (Equine) by Type (2020-2031)
 Figure 54. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Rabies Immune Globulin (Equine) by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Rabies Immune Globulin (Equine) by Application (2020-2031)
 Figure 57. Global Rabies Immune Globulin (Equine) Price (US$/Unit) by Application (2020-2031)
 Figure 58. Rabies Immune Globulin (Equine) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Equine Rabies Immunoglobulin ERIG Market Research Report 2024
Rabies Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Immune Globulin HRIG Market Research Report 2024
Global Human Rabies Immunoglobulin IM Market Research Report 2025
Rabies Immune Globulin Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Immunoglobulins Market Research Report 2024
Global Rh Immunoglobulin Market Research Report 2024
Global Rabies Virus Monoclonal Antibody Market Research Report 2024
Global Rabies Antiserum Market Research Report 2024
Global Human Rabies Vaccine Market Research Report 2024
Animal derived Immune Globulin Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Monoclonal Antibody Market Research Report 2024
Human Rho D Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Vaccination Market Research Report 2025
Global Passive Immunizing Drugs against Rabies Market Research Report 2024
Global RABV G Inhibitors Market Research Report 2024
Global Snake Antivenom Immunoglobulin Market Research Report 2024
Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Vaccine for Pets Market Research Report 2024
Rabies Vaccine Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions